Human stem cells and monoclonal antibodies

Patent Number: 4965204

This patent is a division of application Ser.No. 670,740, filed Feb.6, 1984 which issued on Dec. 22, 1987 as U.S. Pat. No. 4,714,680 and was described below. This patent is similar to 4,714,680 with the exception that the one independent claim in this patent covers in more detail the antibody which is now known to recognize CD34. Inventor: Civin, Curt I. (Baltimore, MD)

Assignee: The Johns Hopkins University (Baltimore, MD)

Date of First Priority Issue: Tuesday December 22nd, 1987

Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood

Patent Number: 5004681

This patent covers freezing of cord blood for future use. The patent has one independent claim covering the composition of a cryopreservant, together with viable fetal or neonatal hematopoietic cells. PharmaStem is the successor to Biocyte Corporation, the assignee of this patent. This patent, together with patents 5 192 553, 6 461 645, 6 569 427 and 6 605 275 are used by Pharmastem to...

Inventors: Boyse, Edward A. (New York, NY); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)

Assignee: Biocyte Corporation (New York, NY)

Date of First Priority Issue: Friday December 11th, 1987

Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood

Patent Number: 6605275

This patent covers preservation of cord blood cells. It is one of the patents that is actually generating revenue and has stood the test of litigation. Anyone doing cord blood banking in the US has to license this patent.

Inventors: Boyse, Edward A. (Tucson, AZ); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)

Assignee: PharmaStem Therapeutics, Inc. (Wayne, PA)

Date of First Priority Issue: Thursday November 12th, 1987

Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood

Patent Number: 6569427

This patent covers the use of cord blood cells. Any cord blood bank in the US has to license this patent or else Pharmastem will litigate as they have in the past.

Inventors: Boyse, Edward A. (Tucson, AZ); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)

Assignee: PharmaStem Therapeutics, Inc. (Del Mar, CA)

Date of First Priority Issue: Thursday November 12th, 1987

Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use

Patent Number: 5192553

This is a patent on freezing cord blood stem cells. This is an important patent since it is generating revenue. The company Pharmastem used this patent and several others in order to position itself in the cord blood industry. Additionally, this patent stood the test of litigation.

Inventors: Boyse, Edward A. (Tucson, AZ); Broxmeyer, Hal E. (Indianapolis, IN); Douglas, Gordon W. (New York, NY)

Assignee: Biocyte Corporation (New York, NY)

Date of First Priority Issue: Thursday November 12th, 1987

Composition and method for supporting bone marrow transplantation

Patent Number: 5186931

This patent provides a composition of cytokines for stimulating hematopoiesis after a bone marrow transplant, as well as for the in vitro stimulation of hematopoiesis. The composition involves B cell differentiation factor and some commonly used cytokines today.

Inventors: Kishimoto, Tadamitsu (Nakano Tondabayashi-shi, Oosaka-fu, JP); Hirano, Toshio (Ibaraki, JP); Akiyama, Yukio (Kawasaki, JP); Okano, Akira (Kawasaki, JP); Matsui, Hiroshi (Kawasaki, JP); Takahara, Yoshiyuki (Kawasaki, JP)

Assignee: Ajinomoto Co., Inc. (Tokyo, JP); Kishimoto, Tadamitsu (Tondabayashi, JP)

Date of First Priority Issue: Wednesday August 6th, 1986

<< | < | 12 13 14 15 16

TOP

Send us your feedback?